Literature DB >> 5636828

Production of antitoxic immunity by live oral cholera vaccine.

P Bhattacharya, A Narayanaswami, S Mukerjee.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 5636828      PMCID: PMC252005          DOI: 10.1128/jb.95.1.255-256.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  3 in total

1.  PATHOGENESIS EXPERIMENTAL CHOLERA IN INFANT RABBITS. I. OBSERVATIONS ON THE INTRAINTESTINAL INFECTION AND EXPERIMENTAL CHOLERA PRODUCED WITH CELL-FREE PRODUCTS.

Authors:  R A FINKELSTEIN; H T NORRIS; N K DUTTA
Journal:  J Infect Dis       Date:  1964-06       Impact factor: 5.226

2.  The titration of cholera toxin and antitoxin in the rabbit ileal loop.

Authors:  G J Kasai; W Burrows
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

3.  Preparation of the vascular permeability factor of Vibrio cholerae.

Authors:  J P Craig
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

  3 in total
  5 in total

1.  Live oral cholera vaccine: report of a trial on human volunteer subjects.

Authors:  S C Sanyal; S Mukerjee
Journal:  Bull World Health Organ       Date:  1969-04       Impact factor: 9.408

2.  Antigenic analysis of vibrio culture filtrate and vaccine El Tor vibrio.

Authors:  S C Sanyal; A Narayanaswami; S Mukerjee
Journal:  J Hyg (Lond)       Date:  1969-09

3.  Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines.

Authors:  R Ganguly; L W Clem; Z Bencić; R Sinha; R Sakazaki; R H Waldman
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

4.  Experimental oral immunization with L-forms of Vibrio cholerae.

Authors:  S C Agarwal; N K Ganguly
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

5.  Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans.

Authors:  R A Cash; S I Music; J P Libonati; A R Schwartz; R B Hornick
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.